Cross-fund · 3 holders
TBPH
THERAVANCE BIOPHARMA INC
CUSIP G8807B106
3
Tracked holders
$115.9M
Aggregate value
6,781,834
Shares
5
Active funds
Funds holding TBPH
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $69.7M | — | +245,765 | +6.1% |
| Vanguard | Institutional | Q4 2025 | $44.3M | — | +155,771 | +7.0% |
| Citadel | Multi-Strategy | Q1 2026 | $1.9M | — | -117,509 | -49.9% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -136,978 | EXITED |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -10,500 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.